1090 related articles for article (PubMed ID: 22393530)
1. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.
Holtzman DM; Herz J; Bu G
Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a006312. PubMed ID: 22393530
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.
Bilousova T; Melnik M; Miyoshi E; Gonzalez BL; Poon WW; Vinters HV; Miller CA; Corrada MM; Kawas C; Hatami A; Albay R; Glabe C; Gylys KH
Am J Pathol; 2019 Aug; 189(8):1621-1636. PubMed ID: 31108099
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.
Zhao N; Liu CC; Qiao W; Bu G
Biol Psychiatry; 2018 Feb; 83(4):347-357. PubMed ID: 28434655
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms.
Kim J; Yoon H; Basak J; Kim J
Mol Cells; 2014 Nov; 37(11):767-76. PubMed ID: 25358504
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV
Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.
Bachmeier C; Shackleton B; Ojo J; Paris D; Mullan M; Crawford F
Neuromolecular Med; 2014 Dec; 16(4):686-96. PubMed ID: 25015123
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.
Liu CC; Liu CC; Kanekiyo T; Xu H; Bu G
Nat Rev Neurol; 2013 Feb; 9(2):106-18. PubMed ID: 23296339
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways.
O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X
Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019
[TBL] [Abstract][Full Text] [Related]
9. Functional role of lipoprotein receptors in Alzheimer's disease.
Jaeger S; Pietrzik CU
Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
[TBL] [Abstract][Full Text] [Related]
10. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
[TBL] [Abstract][Full Text] [Related]
11. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis.
Chen Y; Strickland MR; Soranno A; Holtzman DM
Neuron; 2021 Jan; 109(2):205-221. PubMed ID: 33176118
[TBL] [Abstract][Full Text] [Related]
15. The role of apolipoprotein E in Alzheimer's disease.
Kim J; Basak JM; Holtzman DM
Neuron; 2009 Aug; 63(3):287-303. PubMed ID: 19679070
[TBL] [Abstract][Full Text] [Related]
16. Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.
Castellano JM; Kim J; Stewart FR; Jiang H; DeMattos RB; Patterson BW; Fagan AM; Morris JC; Mawuenyega KG; Cruchaga C; Goate AM; Bales KR; Paul SM; Bateman RJ; Holtzman DM
Sci Transl Med; 2011 Jun; 3(89):89ra57. PubMed ID: 21715678
[TBL] [Abstract][Full Text] [Related]
17. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
[TBL] [Abstract][Full Text] [Related]
18. Sortilin, a novel APOE receptor implicated in Alzheimer disease.
Carlo AS
Prion; 2013; 7(5):378-82. PubMed ID: 24121631
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype regulates amyloid-beta cytotoxicity.
Wilhelmus MM; Otte-Höller I; Davis J; Van Nostrand WE; de Waal RM; Verbeek MM
J Neurosci; 2005 Apr; 25(14):3621-7. PubMed ID: 15814793
[TBL] [Abstract][Full Text] [Related]
20. The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.
Mahoney-Sanchez L; Belaidi AA; Bush AI; Ayton S
J Mol Neurosci; 2016 Nov; 60(3):325-335. PubMed ID: 27647307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
